(1 - 6 von 6
)
Polares Medical Closes a $25M Financing to Enter Clinical Validation
www.b3cnewswire.com
... to clinical evaluation, and to unleash its potential as a game-changer in MR treatment.” said Jacques Essinger, Ph.D, Chairman and CEO.
Missing: Agentur Rauhen Hauses"
Polares Medical closes a $25M financing round Startupticker ...www.startupticker.ch › news › july-2018
www.startupticker.ch
said Jacques Essinger, Ph.D, Chairman and CEO. Polares is a preclinical stage spinoff company of Symetis AG, focused on the development of ...
Missing: Agentur Rauhen Hauses"
SG COWEN "Healthcare" Conference November 27, 2001
media.corporate-ir.net
ImmunoGen, Inc. Mitchel Sayare, Chairman & CEO. 17:30 PM. Serono S.A.* Stuart Grant, VP Corporate Finance. Modex Dr. Jacques Essinger, CEO ...
sortiert nach Relevanz / Datum